Australia markets closed

Neurocrine Biosciences, Inc. (NBIX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
140.71+0.88 (+0.63%)
At close: 04:00PM EDT
142.26 +1.55 (+1.10%)
After hours: 07:55PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 14.16B
Enterprise value 13.46B
Trailing P/E 38.24
Forward P/E 28.57
PEG ratio (5-yr expected) 0.48
Price/sales (ttm)7.29
Price/book (mrq)5.93
Enterprise value/revenue 6.79
Enterprise value/EBITDA 27.09

Trading information

Stock price history

Beta (5Y monthly) 0.28
52-week change 342.83%
S&P500 52-week change 322.38%
52-week high 3148.37
52-week low 389.04
50-day moving average 3137.15
200-day moving average 3122.26

Share statistics

Avg vol (3-month) 3908.06k
Avg vol (10-day) 3925.3k
Shares outstanding 5100.64M
Implied shares outstanding 6100.64M
Float 899.41M
% held by insiders 11.00%
% held by institutions 194.60%
Shares short (15 Apr 2024) 42.02M
Short ratio (15 Apr 2024) 42.26
Short % of float (15 Apr 2024) 42.35%
Short % of shares outstanding (15 Apr 2024) 42.01%
Shares short (prior month 15 Mar 2024) 42.48M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 429 Dec 1995
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 18.65%
Operating margin (ttm)20.43%

Management effectiveness

Return on assets (ttm)10.08%
Return on equity (ttm)18.16%

Income statement

Revenue (ttm)1.98B
Revenue per share (ttm)20.15
Quarterly revenue growth (yoy)22.60%
Gross profit (ttm)N/A
EBITDA 492.9M
Net income avi to common (ttm)369.7M
Diluted EPS (ttm)3.69
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.21B
Total cash per share (mrq)12.03
Total debt (mrq)410.7M
Total debt/equity (mrq)17.21%
Current ratio (mrq)2.52
Book value per share (mrq)23.72

Cash flow statement

Operating cash flow (ttm)645.4M
Levered free cash flow (ttm)719.32M